ADAMA(000553)

Search documents
安道麦A(000553) - 2020 Q4 - 年度财报
2021-03-30 16:00
Financial Performance - Adama's operating revenue for 2020 was 28,444,833 thousand yuan, an increase of 3.20% compared to 2019[11]. - The net profit attributable to shareholders for 2020 was 352,753 thousand yuan, representing a significant increase of 27.33% year-over-year[11]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was 287,724 thousand yuan, a decrease of 52.84% compared to the previous year[11]. - The net cash flow from operating activities reached 2,023,015 thousand yuan, showing a remarkable increase of 139.84% from 2019[11]. - The total assets at the end of 2020 amounted to 46,801,034 thousand yuan, reflecting a growth of 3.34% compared to the end of 2019[11]. - The net assets attributable to shareholders decreased to 21,353,752 thousand yuan, down by 4.55% from the previous year[11]. - The company's sales revenue for 2020 reached RMB 28,444,833 thousand, representing a year-on-year increase of 3.20% compared to RMB 27,563,239 thousand in 2019[30]. - The pre-tax profit for 2020 was RMB 575,212 thousand, showing a significant increase of 27.38% from RMB 451,572 thousand in the previous year[30]. - The net profit for 2020 was RMB 352,753 thousand, which is a 27.33% increase compared to RMB 277,041 thousand in 2019[30]. - The company achieved an EBITDA of RMB 4,088,571 thousand, with an EBITDA margin of 14.4%, down from 15.2% in 2019[30]. Market Position and Strategy - The company emphasizes its strong R&D capabilities and diverse product offerings, serving farmers in over 100 countries[1]. - Adama's future development strategy includes addressing risks such as currency fluctuations and raw material costs[3]. - The company has a strong market position due to its unique formulation technologies and high-quality differentiated products[1]. - The company focuses on developing and marketing non-patented crop protection products, including herbicides, insecticides, and fungicides, catering to local farmer needs globally[15]. - Emerging markets contributed over 50% of the company's total sales in 2020, highlighting the strength of its business in these regions[30]. - The company has a diverse product portfolio, with no single active ingredient accounting for more than 5% of total sales in 2020, enhancing business stability[26]. - The company aims to enhance its market position through a differentiated product portfolio, focusing on high-margin, innovative solutions, including unique mixtures and formulations[93]. - The company plans to leverage its strong R&D capabilities to develop new formulations and delivery technologies, aiming for market-first launches post-patent expiration[94]. Acquisitions and Investments - The company’s acquisition of Adama Solutions resulted in a significant increase in assets, with the investment valued at 18,577,615 thousand yuan[25]. - The company completed acquisitions in Greece and Paraguay, which contributed positively to its performance[39]. - The company acquired Alfa Agricultural Supplies S.A., FNV S.A., and Shanghai Dubai Plant Protection Co., Ltd. during the reporting period, indicating a strategic expansion through mergers and acquisitions[138]. - The company plans to use the raised funds to acquire a 51% stake in Shanghai Dubai, with the acquisition completed on November 16, 2020[80]. Research and Development - The company has established R&D and registration centers in multiple countries, enabling efficient market entry for new products[38]. - Research and development expenses increased by 9.73% year-over-year, totaling 478,778 thousand yuan[58]. - The total research and development investment in 2020 was RMB 478.78 million, representing a 9.36% increase compared to the previous year[67]. Environmental and Regulatory Compliance - The company is classified as a key pollutant discharge unit by environmental protection authorities[168]. - The company has a wastewater treatment facility with a capacity of 20,000 tons/day, achieving compliance with discharge standards for COD, ammonia nitrogen, and total phosphorus[170]. - The company received approval for the environmental impact report for the ultra-low emission renovation project and the pesticide relocation and upgrade project[171]. - The company has implemented a self-monitoring plan for environmental management, including continuous monitoring of wastewater and emissions[173]. Shareholder and Dividend Information - Adama reported a cash dividend of 0.16 RMB per 10 shares for a total of 2,329,811,766 shares, amounting to approximately 373.57 million RMB[3]. - The cash dividend for 2019 was RMB 0.12 per 10 shares, totaling RMB 29,358,642.98, which accounted for 10.6% of the net profit attributable to ordinary shareholders[128]. - The company’s cash dividend policy remains unchanged during the reporting period[124]. - The total cash dividend, including other methods, amounts to 97,676,284.26 RMB, representing 100% of the distributable profit[129]. Risks and Challenges - The company faces challenges in passing on rising procurement costs to sales prices due to intense global competition[18]. - The company expects continued upward pressure on production costs in 2021 due to rising raw material prices and a strong RMB against the USD[19]. - The company faces risks from currency fluctuations, particularly exposure to the Euro, Israeli Shekel, and Brazilian Real, which could impact sales and profitability[98]. - The company is exposed to risks in emerging markets, including political instability and currency volatility, which could negatively affect its operations[100]. - The crop protection market is highly competitive, with seven major multinational companies leading, including Bayer, Syngenta, and BASF, which impacts the company's market share and financial performance[102]. Management and Governance - The company has undergone changes in its board and management structure, with several appointments and resignations in 2020[195]. - The leadership team includes experienced professionals with diverse backgrounds in finance, engineering, and agrochemicals, contributing to strategic decision-making[200]. - The management team is committed to maintaining transparency and providing accurate financial information to stakeholders[200].
安道麦A(000553) - 2020 Q3 - 季度财报
2020-10-29 16:00
安道麦发布 2020 年第三季度与前三季度业绩 业务持续强劲增长 多国货币对美元疲软致利润受损 三季度销售额达 9.78 亿美元,创历史新高,以固定汇率计算同比增长 12%,以美元计算同比增长 3%,以人民币计算同比增长 2%; ‒ 得益于新兴市场持续增长,销售量同比增加 11%,驱动销售额增长; ‒ 多国货币对美元贬值对三季度以美元计算的销售额造成约 8800 万美元影响。 前九个月销售额为 29.87 亿美元,创历史新高,以固定汇率计算同比增长 8%,以美元计算同比增 长 1%,以人民币计算同比增长 3%; ‒ 尽管新冠疫情仍在全球蔓延,对业务造成诸多限制,但销售量仍强劲提升 8%; ‒ 多国货币对美元贬值造成前三季度以美元计算的销售额损失约 2.22 亿美元。 三季度息税及折旧摊销前利润(以下简称"EBITDA")实现 1.3 亿美元,2019 年同期为 1.44 亿美 元;EBITDA 受汇率负面影响金额约为 7100 万美元; ‒ 虽然三季度销售量增长强劲,采购成本下降,但未能完全弥补多国货币对美元仍严重贬值的不 利影响; ‒ 计入多个新近收购公司的费用,当期营业费用仍实现同比下降。 前九个月 EB ...
安道麦A(000553) - 2020 Q3 - 季度财报
2020-10-29 16:00
安道麦股份有限公司 2020 年第三季度报告全文 安道麦股份有限公司 2020 年第三季度报告 作为全球植保行业的领军企业,安道麦股份有限公司为世界各地的农民提供除草、杀虫及杀菌解 决方案。安道麦是全球拥有最广泛且多元化原药产品的企业之一,研发实力雄厚,生产设施与制剂工 艺走在世界前列;在企业文化上倡导赋权增能,鼓励活跃在各个市场前沿的安道麦人倾心听取农民意 见,在田间激发创想。安道麦凭借于此奠定了独特的市场定位,以丰富、独特的复配品种和制剂技术、 以及高质量的差异化产品为基础,将解决方案交付给全球 100 多个国家的农民和客户,满足他们的多 样需求。 更多重点信息及详细内容请参见报告附件。 2020 年 10 月 1 安道麦股份有限公司 2020 年第三季度报告全文 第一节 重要提示 ▪ 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真实、准确、 完整,不存在虚假记载、误导性陈述或重大遗漏,并承担个别和连带的法律责任。 ▪ 公司负责人(总裁兼首席执行官、法定代表人)Ignacio Dominguez、主管会计工作负责 人(首席财务官兼副首席执行官)及会计机构负责人 Aviram Lahav ...
安道麦A(000553) - 2020 Q2 - 季度财报
2020-08-20 16:00
1 安道麦股份有限公司 2020 年半年度报告全文 安道麦股份有限公司 2020 年半年度报告 作为全球植保行业的领军企业,安道麦股份有限公司为世界各地的农民提供除草、杀虫及杀菌解 决方案。安道麦是全球拥有最广泛且多元化原药产品的企业之一,研发实力雄厚,生产设施与制剂工 艺走在世界前列;在企业文化上倡导赋权增能,鼓励活跃在各个市场前沿的安道麦人倾心听取农民意 见,在田间激发创想。安道麦凭借于此奠定了独特的市场定位,以丰富、独特的复配品种和制剂技术、 以及高质量的差异化产品为基础,将解决方案交付给全球 100 多个国家的农民和客户,满足他们的多 样需求。 更多重点信息及详细内容请参见报告附件。 2020 年 8 月 安道麦股份有限公司 2020 年半年度报告全文 第一节 重要提示、目录和释义 ▪ 公司董事会、监事会及董事、监事、高级管理人员保证半年度报告内容的真实、准确、 完整,不存在虚假记载、误导性陈述或重大遗漏,并承担个别和连带的法律责任。 ▪ 公司负责人(总裁兼首席执行官、法定代表人)Ignacio Dominguez、主管会计工作负责 人(首席财务官兼副首席执行官)及会计机构负责人 Aviram Lah ...
安道麦A(000553) - 2020 Q2 - 季度财报
2020-08-20 16:00
面对新冠疫情冲击,安道麦二季度销售业绩恢复增长 受疫情影响多国货币对美元广泛疲软,继续影响销售额增长并压制盈利水平 二季度销售额达 10.36 亿美元,以固定汇率计算同比增长 12%,以美元计算同比增长 3%,以人 民币计算同比增长 8%; ‒ 得益于新兴市场增长强健,销售量同比增长 12%,推动销售额企稳回弹; ‒ 多国货币对美元贬值对二季度以美元计算的销售额造成约 8500 万美元影响。 上半年销售额为 20.08 亿美元,以固定汇率计算同比增长 7%,以美元计算与 2019 年的同期历史 最高记录持平,以人民币计算同比增长 4%; ‒ 一季度经历新冠疫情挑战后,二季度销量总体增长 10%,销售增长带动上半年销售额全面复苏; ‒ 多国货币对美元贬值对上半年以美元计算的销售额造成约 1.35 亿美元影响。 二季度息税及折旧摊销前利润(以下简称"EBITDA")实现 1.63 亿美元,2019 年同期为 1.77 亿美 元;EBITDA 受汇率负面影响金额约为 6100 万美元; ‒ 虽然二季度销售量增长强劲,产品组合得到改善,但未能对冲多国货币严重贬值的不利影响; ‒ 公司继续严控营业费用,并受益于多国货币 ...
安道麦A(000553) - 2020 Q1 - 季度财报
2020-04-27 16:00
Financial Performance - Revenue for the reporting period was 6,782,243 thousand yuan, a slight decrease of 0.08% compared to the same period last year[4] - Net profit attributable to shareholders of the listed company was -16,707 thousand yuan, a significant decrease of 104.56% year-on-year[4] - Basic earnings per share were -0.007 yuan per share, a decrease of 104.67% year-on-year[4] - Revenue for the reporting period was 6,782,243 thousand yuan, a slight decrease of 0.08% compared to the same period last year[11] - Gross profit decreased by 13.41% to 2,024,830 thousand yuan, with gross margin dropping from 34.45% to 29.85%[11] - Net profit turned negative at -16,707 thousand yuan, a significant decline of 104.56% year-over-year[11] - EBITDA decreased by 24.69% to 927,888 thousand yuan, with EBITDA margin falling from 18.15% to 13.68%[11] - Revenue for the first quarter was 6,782,243 thousand yuan, a slight decrease from the previous quarter's 6,787,751 thousand yuan[42] - Operating profit for the first quarter was 134,304 thousand yuan, significantly lower than the previous quarter's 418,600 thousand yuan[42] - Net profit for the first quarter was a loss of 16,707 thousand yuan, compared to a profit of 366,756 thousand yuan in the previous quarter[42] - Comprehensive income attributable to the parent company's owners was 127,500 thousand yuan, a significant improvement from the previous quarter's loss of 23,287 thousand yuan[42] Cash Flow and Liquidity - Net cash flow from operating activities was -384,708 thousand yuan, a decrease of 70.17% compared to the same period last year[4] - Cash flow from operating activities was negative 384,708 thousand yuan, an improvement from the previous quarter's negative 1,289,484 thousand yuan[44] - Cash flow from investing activities was negative 373,099 thousand yuan, an improvement from the previous quarter's negative 1,069,729 thousand yuan[44] - Cash flow from financing activities was positive 629,227 thousand yuan, a decrease from the previous quarter's positive 833,545 thousand yuan[44] - The company's cash and cash equivalents at the end of the quarter were 4,237,919 thousand yuan, a decrease from the previous quarter's 4,319,907 thousand yuan[44] - Sales of goods and services received cash of 309,170 thousand yuan, a decrease of 51.2% compared to the previous period's 633,069 thousand yuan[46] - Cash received from tax refunds increased to 17,306 thousand yuan from 15,759 thousand yuan in the previous period[46] - Total cash inflow from operating activities decreased to 334,675 thousand yuan from 656,565 thousand yuan in the previous period[46] - Cash paid for goods and services decreased to 169,917 thousand yuan from 290,452 thousand yuan in the previous period[46] - Net cash flow from operating activities decreased to 59,343 thousand yuan from 238,276 thousand yuan in the previous period[46] - Net cash flow from investing activities was negative 32,861 thousand yuan, compared to negative 24,042 thousand yuan in the previous period[46] - Net cash flow from financing activities was positive 13,270 thousand yuan, compared to negative 9,687 thousand yuan in the previous period[46] - The net increase in cash and cash equivalents was 43,348 thousand yuan, a significant decrease from 199,770 thousand yuan in the previous period[46] - The ending balance of cash and cash equivalents was 1,439,342 thousand yuan, compared to 2,205,083 thousand yuan in the previous period[46] Assets and Liabilities - Total assets at the end of the reporting period were 47,780,240 thousand yuan, an increase of 5.50% compared to the end of the previous year[4] - Net assets attributable to shareholders of the listed company were 22,500,143 thousand yuan, an increase of 0.57% compared to the end of the previous year[4] - Total assets increased to 47,780,240 thousand yuan as of March 31, 2020, compared to 45,288,940 thousand yuan at the end of 2019[39] - Current assets rose to 27,638,597 thousand yuan, up from 25,142,226 thousand yuan at the end of 2019[39] - Accounts receivable increased to 8,577,783 thousand yuan, up from 8,004,157 thousand yuan at the end of 2019[39] - Inventory grew to 10,091,315 thousand yuan, compared to 9,932,654 thousand yuan at the end of 2019[39] - Total liabilities increased to 25,280,097 thousand yuan, up from 22,917,275 thousand yuan at the end of 2019[39] - Short-term borrowings rose to 2,515,622 thousand yuan, compared to 2,009,882 thousand yuan at the end of 2019[39] - Long-term borrowings increased to 1,181,250 thousand yuan, up from 927,159 thousand yuan at the end of 2019[39] - Total equity slightly increased to 22,500,143 thousand yuan, compared to 22,371,665 thousand yuan at the end of 2019[39] - Cash and cash equivalents decreased to 4,264,450 thousand yuan, down from 4,348,588 thousand yuan at the end of 2019[39] - The company's total assets on a standalone basis were 19,896,661 thousand yuan as of March 31, 2020, slightly down from 19,993,212 thousand yuan at the end of 2019[40] Derivative Investments - Derivative financial assets increased by 273.38% to RMB 1,829,988 thousand compared to the end of the previous year[27] - Derivative financial liabilities rose by 144.02% to RMB 1,687,360 thousand due to derivative disposal and value re-evaluation[27] - The company's derivative investments totaled 21,201,548 thousand yuan, with a final investment amount of 21,532,509 thousand yuan, accounting for 95.70% of the company's net assets at the end of the reporting period[35] - The company's derivative investments generated an actual profit of 246,392 thousand yuan during the reporting period[35] - The company's derivative investments were funded entirely with its own capital[35] - The company's derivative investments were primarily in options and forward contracts, with initial investment amounts of 2,078,908 thousand yuan and 19,122,640 thousand yuan, respectively[35] - The company's derivative investments were conducted with large, key banks to mitigate credit and liquidity risks[35] - The company's derivative investments were managed using approved computer software and detailed guidelines approved by the subsidiary's board of directors[35] - The company's derivative investments were subject to quarterly and local internal control audits to ensure compliance and risk management[35] - The company's derivative investments were evaluated for fair value by external experts, with the company's accounting department providing exchange rates and external experts providing other parameters[35] - The company's derivative investment policies and accounting principles remained unchanged from the previous reporting period[35] - The company's independent directors affirmed that the derivative investments were conducted to hedge market risks and were in compliance with relevant laws and regulations[35] Regional Sales Performance - Q1 revenue reached $973 million, a 2% year-over-year growth at constant exchange rates, but a 3% decline in USD terms due to currency depreciation[13] - Europe sales grew 2.7% at constant exchange rates, but declined 1% in USD terms to $357 million[14][15] - North America sales fell 6.7% to $168 million, impacted by COVID-19's effect on consumer and professional solutions demand[14][15] - Latin America sales grew 12.5% at constant exchange rates but declined 0.3% in USD terms to $159 million, with strong performance in Peru and Mexico[14][16] - Asia-Pacific sales dropped 14.9% to $158 million, with China sales down 27.1% due to temporary production halt at Jingzhou base[14][18] - India, Middle East & Africa sales grew 12.5% at constant exchange rates and 8.3% in USD terms to $131 million, driven by strong performance in India and South Africa[14][19] COVID-19 Impact - The COVID-19 pandemic severely impacted global operations, causing temporary shutdowns at the Jingzhou base and increased logistics costs[9] - Currency fluctuations, particularly in Brazil, Australia, Turkey, and India, negatively affected Q1 performance[9] - The company plans to strengthen distribution channels, optimize logistics, and potentially adjust prices to mitigate pandemic impacts[10] Shareholder Information - China National Chemical Agriculture Co., Ltd. holds 74.02% of the company's shares, totaling 1,810,883,039 shares[7] - The top 10 shareholders collectively hold approximately 84.38% of the company's shares[7] - No share repurchase transactions were conducted by the top 10 shareholders during the reporting period[8] Research and Development - The company's R&D strength and production facilities are at the forefront of the global agrochemical industry[2] - Research and development expenses for the first quarter were 92,008 thousand yuan, a decrease from the previous quarter's 96,353 thousand yuan[42] Non-Recurring Items - Non-recurring gains and losses amounted to -33,520 thousand yuan, primarily due to expenses related to an employee early retirement plan[5] - Employee early retirement costs in Israel amounted to $8.6 million[23] Operational Expenses - Operating expenses were controlled, with $9.6 million impact from amortization of 2011 acquisition costs and $7.9 million from 2017 Syngenta-related asset transfers[21] - Sales expenses for the first quarter were 1,256,871 thousand yuan, a slight decrease from the previous quarter's 1,268,966 thousand yuan[42] Financial Expenses and Income - Financial expenses (pre-hedging) for Q1 2020 were RMB 412 million (USD 59 million), compared to RMB 479 million (USD 71 million) in the same period of 2019[24] - Net gains from fair value changes and investment income in Q1 2020 were RMB 194 million (USD 28 million), down from RMB 244 million (USD 36 million) in Q1 2019[24] - Total net financial expenses and investment income for Q1 2020 were RMB 217 million (USD 31 million), a decrease from RMB 236 million (USD 35 million) in Q1 2019[25] Product Launches - New product launches included EMINENT® in Argentina, UBERTOP® in Mexico, and QUALIPRO ENCLAVE® in Australia[18] Corporate Governance - The company's leadership, including the CEO and CFO, has confirmed the accuracy and completeness of the financial report[3] - The company's first quarter report for 2020 was not audited[48] Strategic Initiatives - The company announced its intention to join the Syngenta Group in January 2020, which is expected to become a leading global agricultural enterprise[28] - The company will receive compensation in shares from its parent company, reducing the parent's direct and indirect shareholding from 78.9% to 78.0%[31] Contract Liabilities and Deferred Taxes - Contract liabilities increased by 33.72% to RMB 888,232 thousand, reflecting seasonal growth in rebates[27] - Deferred tax liabilities grew by 38.41% to RMB 447,499 thousand, mainly due to changes in the tax basis of non-monetary assets in Brazil[27]
安道麦A(000553) - 2019 Q4 - 年度财报
2020-04-27 16:00
Financial Performance - Adama reported a revenue of RMB 2,446,553,582 for the year 2019, with a cash dividend of RMB 0.12 per 10 shares proposed for distribution to shareholders[3]. - The company's operating revenue for 2019 was 27,563,239 thousand yuan, an increase of 2.59% compared to the previous year[12]. - The net profit attributable to shareholders for 2019 was 277,041 thousand yuan, a decrease of 88.68% year-on-year[12]. - The net profit after deducting non-recurring gains and losses was 610,059 thousand yuan, down 29.02% from the previous year[12]. - The net cash flow from operating activities was 843,487 thousand yuan, a decline of 63.31% compared to the previous year[12]. - The total assets at the end of 2019 were 45,288,940 thousand yuan, reflecting a 2.61% increase from the end of 2018[12]. - The net assets attributable to shareholders at the end of 2019 were 22,371,665 thousand yuan, a decrease of 1.64% compared to the end of 2018[12]. - The gross profit for 2019 was RMB 8,799,324 thousand, with a gross margin of 32%, down from 33% in 2018[28]. - The pre-tax profit plummeted to RMB 451,572 thousand, reflecting an 86.04% decrease from RMB 3,235,708 thousand in the previous year[28]. - The net profit for 2019 was RMB 277,041 thousand, an 88.47% decline compared to RMB 2,402,462 thousand in 2018[28]. Market Position and Strategy - The company emphasizes its strong R&D capabilities and diverse product offerings, serving farmers in over 100 countries[2]. - Adama operates in approximately 100 countries, focusing on the development and marketing of non-patented crop protection products[17]. - The group holds a leading position in the non-patent crop protection market, with no single active ingredient accounting for over 5% of sales in 2019, enhancing business stability[22]. - The group has established a strong domestic market position in China, leveraging its integration with Syngenta Group and aiming to lead the fragmented crop protection market[24]. - The company aims to leverage expiring patents to develop new crop protection products, enhancing its competitive advantage in the agricultural market[58]. - The company plans to enhance its market position by introducing differentiated, high-quality products that meet farmers' needs, focusing on innovative solutions and complex formulations[85]. - The company recognizes the increasing market share of non-patented products as a trend that may reshape the competitive landscape in the crop protection industry[84]. Research and Development - The company has a strong commitment to listening to farmers' feedback to enhance its market offerings[2]. - The management team possesses extensive industry knowledge and experience, focusing on maintaining leadership and financial strength[27]. - The company's R&D investment amounted to 437,802 thousand yuan in 2018, showing a slight decrease of 1.01% compared to 442,253 thousand yuan in 2017[59]. - The number of R&D personnel increased to 269 in 2019, representing a growth of 5.91% from 254 in 2018[59]. Acquisitions and Investments - The company completed several acquisitions in 2019, including AgroKlinge in Peru and SFP in France-Switzerland, to strengthen its market position[31]. - The company acquired Jiangsu Anbang Chemical Co., Bonide Products INC, Agro Klinge S.A., and SFP during the reporting period, indicating market expansion efforts[149]. - The acquisition of Bonide Products, Inc. allows the company to directly offer advanced pest control solutions to consumers in the U.S. market[80]. Challenges and Risks - The company faced challenges due to severe weather conditions and trade tensions, impacting crop planting and sales efficiency[30]. - The company is exposed to potential civil and criminal liabilities due to non-compliance with environmental regulations, which could lead to substantial fines and operational disruptions[102]. - The crop protection market is highly competitive, dominated by seven multinational companies, with the top five holding 60% of the market share, posing a threat to the company's market position[98]. - The company faces significant risks from currency fluctuations, particularly with the Euro, Israeli Shekel, and Brazilian Real, which can impact sales and profitability[94]. - The company anticipates continued high prices and tight product supply in the agricultural chemical market, driven by increased production costs and regulatory measures in China[83]. Environmental and Social Responsibility - The company has maintained a high compliance record in environmental protection and took specific measures to meet regulatory requirements[154]. - The company is committed to sustainable development and community education initiatives[171]. - The company allocated a total of 763,500 RMB (76.35 million RMB) for poverty alleviation efforts in 2019, including 77,000 RMB (7.7 million RMB) in funds and 686,500 RMB (68.65 million RMB) in material donations[174]. - The company operates wastewater treatment facilities with a design capacity of 37,400 tons/day and 11,000 tons/day, which are currently functioning normally and meeting discharge standards for COD and ammonia nitrogen[177]. Corporate Governance - The board of directors has approved the annual report, ensuring the accuracy and completeness of the financial statements[3]. - The company has conducted 35 investor meetings with 33 institutions and 5 individuals throughout the reporting period[123]. - The company has not disclosed any significant undisclosed information during investor communications[123]. - The company appointed Ignacio Dominguez as the new CEO effective March 1, 2020, following the transition of Chen Lichtenstein to a strategic role at Syngenta Group[184].
安道麦A(000553) - 2020 Q1 - 季度财报
2020-04-27 16:00
面对新冠疫情压力,安道麦 2020 年一季度实现业务增长 全球货币因疫情原因大幅贬值,影响美元销售额与利润 一季度销售额为 9.73 亿美元,以固定汇率计算同比增长 2%,以美元计算同比下降 3%; ‒ 拉美区与印度、中东及非洲区业务稳定增长;尽管定价环境疲软,欧洲销售额以本地货币计算 实现同比增长; ‒ 以固定汇率计算,销售额受新冠疫情影响金额约 4700 万美元; ‒ 因新冠疫情连带其它因素导致各国货币广泛贬值(特别是巴西雷亚尔、欧元及澳元),在上述 影响基础上,以美元计算的销售额进一步受货币贬值影响约 5000 万美元。 一季度息税折旧及摊销前利润(以下简称"EBITDA")实现 1.42 亿美元,汇率走势不利影响 3400 万美元 EBITDA; ‒ 全球汇率走势造成严重不利影响,销售价格承压(以欧洲与中国市场为主),供应端压力继续 影响采购成本,对利润率提出严峻挑战; ‒ 除汇率影响外,一季度 EBITDA 受新冠疫情影响金额约 2000 万美元; ‒ 尽管新成员公司带入相应费用,湖北省荆州基地受疫情影响临时停产产生停工费用,公司继续 严控营业费用并节省可观金额。 一季度净利润实现 2700 万美元 ...
安道麦A(000553) - 2019 Q3 - 季度财报
2019-10-30 16:00
1 安道麦股份有限公司 2019 年第三季度报告全文 安道麦股份有限公司 2019 年第三季度报告 安道麦股份有限公司作为全球作物保护领军企业之一,始终致力于"创简农业",给农民提供高效 的产品和服务,简便农民的耕作生活,帮助农民发展。安道麦拥有最丰富且多元化的差异化优质产品 线,凭借 7000 名员工的优秀团队与全球一百多个国家的农民深入接触,向农民提供除草、杀虫和杀 菌的解决方案,帮助农民提高产量。 更多重点信息及详细内容请参见报告附件。 2019 年 10 月 安道麦股份有限公司 2019 年第三季度报告全文 第一节 重要提示 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真实、准确、完 整,不存在虚假记载、误导性陈述或者重大遗漏,并承担个别和连带的法律责任。 公司所有董事均出席了审议本次季报的董事会会议。 公司负责人及法定代表人 Chen Lichtenstein、主管会计工作负责人(首席财务官)及会 计机构负责人 Aviram Lahav 声明:保证季度报告中财务报表的真实、准确、完整。 本报告全文及正文以中英双语编制。如果对两个版本的理解存在任何差异,以中文版本 为准。 2 安道麦 ...
安道麦A(000553) - 2019 Q3 - 季度财报
2019-10-30 16:00
安道麦克服今年以来的重重挑战 第三季度与前三季度销售额均增长强劲,创同期历史新高 第三季度销售额达到 9.53 亿美元,实现历史新高,以美元计算同比增长 9%,以本地货币计算同 比增长 11% ‒ 在北美区稳健复苏、拉美与欧洲业绩突出的带动下,几乎所有地区均实现业务强劲增长; ‒ 各区域销售价格平均增幅超过 2%; ‒ 由于荆州基地老厂区生产运行尚不平稳导致部分高需求产品供应不足,三季度影响销售额 5500 万美元;目前老厂区仍在逐步恢复生产中; ‒ 前九个月销售额创历史新高,达到 29.62 亿美元,以美元和本地货币计算均超越去年同期,克 服了今年以来市场和供应的重重挑战以及货币走软的不利影响; ‒ 荆州基地老厂区生产运行尚不平稳,前九个月影响销售额 1.62 亿美元; ‒ 中国区除荆州基地老厂区产品之外的品牌制剂产品在第三季度和前九个月的销售额增幅均超过 25%。 第三季度毛利同比增长 6%,实现 2.95 亿美元 ‒ 毛利率为 31.0%,去年同期为 32.0%; ‒ 前九个月毛利实现 9.68 亿美元,毛利率为 32.7%,去年同期为 33.3%; ‒ 公司上调销售价格,以抵消采购成本增加与多国货币疲 ...